Corcept Therapeutics Inc (FRA:HTD) Stock News, Headlines & Updates
Corcept Therapeutics Inc Stock News from GuruFocus
- 1
Jul 30, 2024
Corcept Therapeutics Inc (CORT) Q2 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and Positive Clinical Developments
GuruFocus Research • 5:00am
Q2 2024 Corcept Therapeutics Inc Earnings Call Transcript
GuruFocus Research • 4:02am
Jul 29, 2024
Corcept Therapeutics Announces Second Quarter Financial Results and Provides Corporate Update
Marketwired • 4:00pm
Corcept Therapeutics Inc (CORT) Q2 2024 Earnings: EPS of $0.32 Beats Estimates, Revenue Surges to $163.8 Million
GuruFocus Research • 3:33pm
Jul 22, 2024
Corcept Therapeutics to Announce Second Quarter Financial Results, Provide Corporate Update and Host Conference Call
Marketwired • 4:00pm
Jun 24, 2024
Corcept Announces Presentation of Results From Prevalence Phase of CATALYST Clinical Trial at American Diabetes Association's Scientific Sessions
Marketwired • 4:00pm
Jun 06, 2024
Insider Sale: Chief Development Officer William Guyer Sells 10,000 Shares of Corcept Therapeutics Inc (CORT)
GuruFocus Research • 12:58am
Jun 03, 2024
Corcept Therapeutics Announces Presentations of Results of Pivotal Phase 3 GRACE Trial Evaluating Relacorilant in Patients with Hypercortisolism (Cushing's Syndrome)
Marketwired • 8:00am
May 31, 2024
Insider Sale: Chief Development Officer William Guyer Sells 30,000 Shares of Corcept Therapeutics Inc (CORT)
GuruFocus Research • 1:12am
May 28, 2024
- 1
Show
Entries
Headlines
Total 0- 1
No recent news